Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huanyu Kangcheng is a Beijing-based medical technology company dedicated to improving the diagnosis and management of rare diseases through integrated digital and genetic solutions. The company operates a comprehensive rare disease platform that combines advanced genetic testing, clinical decision support, and patient-centric services to reduce the time to diagnosis. By collaborating with leading medical institutions and pharmaceutical partners, Huanyu Kangcheng facilitates access to specialized care and innovative therapies for patients with orphan diseases. Their core expertise lies in bioinformatics and the application of big data to identify genetic variants associated with complex clinical phenotypes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huanyu Kangcheng.